These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37508292)

  • 21. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
    Chong WH; Saha BK; Neu KP
    Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria.
    Tetaj N; Capone A; Stazi GV; Marini MC; Garotto G; Busso D; Scarcia S; Caravella I; Macchione M; De Angelis G; Di Lorenzo R; Carucci A; Antonica MV; Gaviano I; Inversi C; Agostini E; Canichella F; Taloni G; Evangelista F; Onnis I; Mogavero G; Lamanna ME; Rubino D; Di Frischia M; Porcelli C; Cesi E; Antinori A; Palmieri F; D'Offizi G; Taglietti F; Nisii C; Cataldo MA; Ianniello S; Campioni P; Vaia F; Nicastri E; Girardi E; Marchioni L;
    J Anesth Analg Crit Care; 2022 Aug; 2(1):36. PubMed ID: 37386603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients.
    Shah M; Reveles K; Moote R; Hand E; Kellogg Iii D; Attridge RL; Maselli DJ; Gutierrez GC
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad062. PubMed ID: 36879627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID).
    Abelenda-Alonso G; Rombauts A; Gudiol C; Oriol I; Simonetti A; Coloma A; Rodríguez-Molinero A; Izquierdo E; Díaz-Brito V; Sanmartí M; Padullés A; Grau I; Ras M; Bergas A; Guillem L; Blanco-Arévalo A; Alvarez-Pouso C; Pallarés N; Videla S; Tebé C; Carratalà J
    Clin Microbiol Infect; 2021 Nov; 27(11):1685-1692. PubMed ID: 34242804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.
    Gáspár Z; Szabó BG; Andrikovics H; Ceglédi A; Rajmon M; Ábrahám A; Várnai Z; Kiss-Dala N; Szlávik J; Sinkó J; Vályi-Nagy I; Lakatos B
    Geroscience; 2024 Jun; 46(3):2863-2877. PubMed ID: 38367195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia.
    Estella Á; Recuerda Núñez M; Lagares C; Gracia Romero M; Torres E; Alados Arboledas JC; Antón Escors Á; González García C; Sandar Núñez D; López Prieto D; Sánchez Calvo JM
    J Fungi (Basel); 2023 Feb; 9(3):. PubMed ID: 36983456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary.
    Szabo BG; Lakatos B; Bobek I; Szabo E; Szlavik J; Vályi-Nagy I
    J Mycol Med; 2021 Dec; 31(4):101198. PubMed ID: 34428666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilator Acquired Pneumonia in COVID-19 ICU Patients: A Retrospective Cohort Study during Pandemia in France.
    Moreno J; Carvelli J; Lesaux A; Boucekine M; Tonon D; Bichon A; Gainnier M; Bourenne J
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675351
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Andrianopoulos I; Maniatopoulou T; Lagos N; Kazakos N; Papathanasiou A; Papathanakos G; Koulenti D; Kittas C; Koulouras V
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care.
    Taramasso L; Magnasco L; Portunato F; Briano F; Vena A; Giacobbe DR; Dentone C; Robba C; Ball L; Loconte M; Patroniti N; Frisoni P; D'Angelo R; Dettori S; Mikulska M; Pelosi P; Bassetti M
    Eur J Intern Med; 2021 Dec; 94():39-44. PubMed ID: 34511338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave.
    Meawed TE; Ahmed SM; Mowafy SMS; Samir GM; Anis RH
    J Infect Public Health; 2021 Oct; 14(10):1375-1380. PubMed ID: 34420902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
    Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
    J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Rates of Ventilator-Associated Pneumonia and COVID-19 Associated Pulmonary Aspergillosis in Critically Ill Patients with SARS-CoV2 Infection in the Second Wave: A Retrospective Chart Review.
    Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco.
    Aissaoui Y; Ennassimi Y; Myatt I; El Bouhiaoui M; Nabil M; Bahi M; Arsalane L; Miloudi M; Belhadj A
    PLoS One; 2022; 17(12):e0278175. PubMed ID: 36454978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Significance of Aspergillus Detected in Lower-Respiratory-Tract Samples of Critically Ill COVID-19-Positive Patients.
    Osman H; Shaik AN; Nguyen PL; Cantor Z; Kaafarani M; Soubani AO
    Adv Respir Med; 2023 Sep; 91(5):337-349. PubMed ID: 37736973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.